Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZO-Y60 Phase III clinical trial
jRCT1080221685Phase 3
- Sponsor
- Zeria Pharmaceutical Co., Ltd.
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of nastorazepide in gastrointestinal conditions, sponsored by Zeria Pharmaceutical Co., Ltd.
02
Drugs
nastorazepide
03
Conditions
gastrointestinal conditions
Beyond the preview
Go deeper on jRCT1080221685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080221685.